9 results
8-K
EX-99.1
CERE
Cerevel Therapeutics Holdings Inc
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am
million, and through streamlining of operations, increasing employee engagement, and more focused research and development supported by significant
424B4
CERE
Cerevel Therapeutics Holdings Inc
2 Jul 21
Prospectus supplement with pricing info
5:22pm
annual incentive plan goals for 2021. We also regularly conduct surveys to gauge employee engagement and to create an ongoing open dialogue with our
DRS
yhiusqv5v4pahu1l7f2
27 May 21
Draft registration statement
12:00am
424B3
6sfvl6v7c7
26 Mar 21
Prospectus supplement
4:31pm
POS AM
y366114 k1dq
24 Mar 21
Prospectus update (post-effective amendment)
5:13pm
10-K
ow7mlnik7h
24 Mar 21
Annual report
4:20pm
- Prev
- 1
- Next